.

Deeper Knowledge, Faster

  • Find suppliers and generic API sources
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Queensland Health
Mallinckrodt
Chubb
Chinese Patent Office
Julphar
Medtronic
AstraZeneca
Dow
Cipla
Cantor Fitzgerald

Generated: July 25, 2017

DrugPatentWatch Database Preview

Paddock Company Profile

« Back to Dashboard

What is the competitive landscape for PADDOCK, and what generic and branded alternatives to PADDOCK drugs are available?

PADDOCK has forty-seven approved drugs.

There is one tentative approval on PADDOCK drugs.

Summary for Applicant: Paddock

Patents:0
Tradenames:43
Ingredients:39
NDAs:47
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Paddock Llc
ATOVAQUONE
atovaquone
SUSPENSION;ORAL207833-001Apr 28, 2017ABRXNoNo► Subscribe► Subscribe► Subscribe
Paddock Llc
MIDAMOR
amiloride hydrochloride
TABLET;ORAL018200-001Approved Prior to Jan 1, 1982ABRXYesNo► Subscribe► Subscribe► Subscribe
Paddock Llc
DIHYDROERGOTAMINE MESYLATE
dihydroergotamine mesylate
INJECTABLE;INJECTION040475-001Apr 28, 2003APRXNoNo► Subscribe► Subscribe► Subscribe
Paddock Llc
COLOCORT
hydrocortisone
ENEMA;RECTAL075172-001Dec 3, 1999ABRXNoNo► Subscribe► Subscribe► Subscribe
Paddock Llc
REPAGLINIDE
repaglinide
TABLET;ORAL201189-003Jan 22, 2014ABRXNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Similar Applicant Names

Individual applicants are sometimes listed under multiple names.
Here is a list of applicants with similar names.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Chinese Patent Office
Harvard Business School
Queensland Health
Merck
Novartis
Cerilliant
US Department of Justice
Citi
AstraZeneca
Cantor Fitzgerald

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot